Institution
Tabriz University of Medical Sciences
Education•Tabriz, Iran•
About: Tabriz University of Medical Sciences is a education organization based out in Tabriz, Iran. It is known for research contribution in the topics: Population & Cancer. The organization has 11499 authors who have published 17525 publications receiving 241099 citations.
Topics: Population, Cancer, Medicine, Solubility, Randomized controlled trial
Papers published on a yearly basis
Papers
More filters
Theo Vos1, Amanuel Alemu Abajobir, Kalkidan Hassen Abate2, Cristiana Abbafati3 +775 more•Institutions (305)
TL;DR: The Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) provides a comprehensive assessment of prevalence, incidence, and years lived with disability (YLDs) for 328 causes in 195 countries and territories from 1990 to 2016.
10,401 citations
TL;DR: Global health has steadily improved over the past 30 years as measured by age-standardised DALY rates, and there has been a marked shift towards a greater proportion of burden due to YLDs from non-communicable diseases and injuries.
5,802 citations
Christopher J L Murray1, Christopher J L Murray2, Christopher J L Murray3, Aleksandr Y. Aravkin3 +2269 more•Institutions (286)
TL;DR: The largest declines in risk exposure from 2010 to 2019 were among a set of risks that are strongly linked to social and economic development, including household air pollution; unsafe water, sanitation, and handwashing; and child growth failure.
3,059 citations
TL;DR: The FCV-19S, a seven-item scale, has robust psychometric properties and is reliable and valid in assessing fear of COVID-19 among the general population and will also be useful in allaying CO VID-19 fears among individuals.
Abstract: Background: The emergence of the COVID-19 and its consequences has led to fears, worries, and anxiety among individuals worldwide. The present study developed the Fear of COVID-19 Scale (FCV-19S) t ...
2,546 citations
TL;DR: This paper summarizes exclusively scalable techniques and focuses on strengths and limitations in respect to industrial applicability and regulatory requirements concerning liposomal drug formulations based on FDA and EMEA documents.
Abstract: Liposomes, sphere-shaped vesicles consisting of one or more phospholipid bilayers, were first described in the mid-60s. Today, they are a very useful reproduction, reagent, and tool in various scientific disciplines, including mathematics and theoretical physics, biophysics, chemistry, colloid science, biochemistry, and biology. Since then, liposomes have made their way to the market. Among several talented new drug delivery systems, liposomes characterize an advanced technology to deliver active molecules to the site of action, and at present, several formulations are in clinical use. Research on liposome technology has progressed from conventional vesicles to ‘second-generation liposomes’, in which long-circulating liposomes are obtained by modulating the lipid composition, size, and charge of the vesicle. Liposomes with modified surfaces have also been developed using several molecules, such as glycolipids or sialic acid. This paper summarizes exclusively scalable techniques and focuses on strengths, respectively, limitations in respect to industrial applicability and regulatory requirements concerning liposomal drug formulations based on FDA and EMEA documents.
2,374 citations
Authors
Showing all 11569 results
| Name | H-index | Papers | Citations |
|---|---|---|---|
| Mohammadali Mohajel Shoja | 41 | 474 | 7414 |
| Farhad Jadidi-Niaragh | 41 | 186 | 5769 |
| Amir Mohammad Mortazavian | 41 | 215 | 4899 |
| Lutfun Nahar | 41 | 342 | 7537 |
| Ali Ahmadi | 41 | 389 | 6666 |
| Mir Ali Farajzadeh | 40 | 278 | 5738 |
| Saeid Safiri | 40 | 376 | 32616 |
| Hadi Valizadeh | 40 | 228 | 5381 |
| Bahman Yousefi | 39 | 242 | 6813 |
| Hossein Samadi Kafil | 39 | 322 | 5758 |
| Mohammad Barzegar-Jalali | 38 | 199 | 5627 |
| Ahad Mokhtarzadeh | 38 | 188 | 3914 |
| Jafar Ezzati Nazhad Dolatabadi | 38 | 80 | 2816 |
| Siamak Sabour | 36 | 420 | 5762 |
| Reza Heidari | 34 | 177 | 3211 |